Teva makes generic, biosimilar and branded medicines for patients, pharmacies and healthcare providers. It last closed at $42.61 on Nov 17, up 0.09% on the day. TEVA reports earnings on Wed, Jan 27, 2027. The average 12-month price target from 9 analysts is $51.56 (+21.0% from the last close), with a high of $57.00 and a low of $47.00. Analyst consensus is Strong Buy, based on the latest ratings from 9 firms (9 buy, 0 hold, 0 sell). Over the past 90 days StreetAlpha recorded 2 whale options trades in TEVA, 50% of them bullish and 50% bearish. In the past 30 days there were 7 dark pool prints totaling $28.1M, the largest $21.1M.
Each firm's latest rating on TEVA in the past 90 days
Average 12-month target
$51.56
▲ 21.0% upside
Based on 9 analysts who set a price target on TEVA in the past 90 days. The average target is $51.56, with a high of $57.00 and a low of $47.00, compared with the last close of $42.61.
Highest target$57.00
Average target$51.56
Lowest target$47.00
Latest rating changes
Argus ResearchMaintained
Nov 17Buy$50
HC Wainwright & Co.Reiterated
Nov 17Buy$54
Piper SandlerTarget raised
Nov 12Buy$44 → $56
Leerink PartnersTarget raised
Nov 5Buy$45 → $52
TD CowenTarget raised
Nov 4Buy$55 → $57
Date
Firm
Action
Rating
Price target
Nov 17
Argus Research
Maintained
Buy
$50
Nov 17
HC Wainwright & Co.
Reiterated
Buy
$54
Nov 12
Piper Sandler
Target raised
Buy
$44 → $56
Nov 5
Leerink Partners
Target raised
Buy
$45 → $52
Nov 4
TD Cowen
Target raised
Buy
$55 → $57
Loading…
Technical Analysis
TEVA · as of the Nov 17 close · updated after every close
Uptrend
The stock is 2% above its 20 day and 5% above its 50 day average. It is 17% above its 200 day average, so the longer trend is still up. Momentum is strong (RSI 56). The nearest support is the Pivot at $42.29, and the nearest resistance the Pivot R1 at $43.01.
Short trendBullish
Long trendBullish
MomentumStrong
StretchNormal
VolatilityNormal, 3.0%/day
Key levels
$44.5752 week high+4.6%
$43.34Swing high (Nov 3)+1.7%
$43.01Pivot R1+0.9%
$42.61Last close
$42.29Pivot−0.8%
$41.88Pivot S1−1.7%
$41.7420 day average−2.0%
$40.4250 day average−5.1%
$39.10Swing low (Oct 23)−8.2%
$37.55100 day average−11.9%
$35.18200 day average−17.4%
$24.0152 week low−43.7%
Indicators
RSI (14)
55.66
Middle of its range
Neutral
MACD
0.87
Above its signal line
Bullish
Stochastic
72.2
Middle of its range
Neutral
ADX (14)
22.9
Weak trend
Williams %R
-43.0
Oversold below −80, overbought above −20
Neutral
CCI (20)
35.4
Oversold below −100, overbought above 100
Neutral
Rate of change
+1.7%
Change over 10 sessions
Bullish
ATR (14)
$1.26
Typical daily range, 3.0% of price
MA 10Below
MA 20Above
MA 50Above
MA 100Above
MA 200Above
Rising, nearing overbought
Short trendBullish
Long trendNot enough history
MomentumStrong
StretchNear overbought
VolatilityNormal, 6.1%/day
Key levels
$44.5752 week high+4.6%
$43.34Swing high (Nov 3)+1.7%
$43.01Pivot R1+0.9%
$42.61Last close
$42.29Pivot−0.8%
$41.88Pivot S1−1.7%
$41.7420 day average−2.0%
$40.4250 day average−5.1%
$39.10Swing low (Oct 23)−8.2%
$37.55100 day average−11.9%
$35.18200 day average−17.4%
$24.0152 week low−43.7%
Indicators
RSI (14)
64.23
Strong, overbought above 70
Neutral
MACD
2.73
Above its signal line
Bullish
Stochastic
90.1
Near the top of its range
Overbought
ADX (14)
29.4
Trending up
Williams %R
-21.4
Oversold below −80, overbought above −20
Neutral
CCI (20)
110.9
Oversold below −100, overbought above 100
Overbought
Rate of change
+14.9%
Change over 10 sessions
Bullish
ATR (14)
$2.62
Typical daily range, 6.1% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200–
What happened before, for TEVA
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how TEVA did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
November seasonalityHow TEVA usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How TEVA has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2006.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether TEVA is in one of them and how their past TEVA trades turned out.
Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.
About Teva Pharmaceutical Industries
Teva is a pharmaceutical company based in Tel Aviv. It makes generic medicines, biosimilars that copy complex biologic drugs, and branded medicines for conditions such as movement disorders, migraine and schizophrenia. Its customers include pharmacies, hospitals, physicians, patients and third-party payers such as health insurers. Its products are sold in markets around the world.